It is vital that the Food and Drug Administration routinely incorporate the patient perspective in its decisionmaking process.

This is a good thing because it will get safe and effective products to doctors and to patients faster.

But, make no mistake about it, we are getting our work done.

Thank you for your leadership. You have done great work.

Let's continue to build upon these remarkable and bipartisan advancements that put patients first.

I think I have heard it said more than once today on the panel in front of us the words 'alleviate suffering'.

I thank the gentleman for yielding. Mr. Speaker, we all know why we are here--the problems that exist within the Affordable Care Act. It is simply not working for the American people--limited choice, costs going up, and millions without…

Patients have the most at stake and they deserve to be heard.

This year will mark the fifth renewal by Congress, and it is widely agreed that the prescription drug user fee agreements will provide for the timely review of new drug and new biologic license applications.

I would be remiss not to mention the President's proposed budget which seeks to cut EPA by 31 percent.

Will the gentleman maintain his position for just a moment so perhaps we can engage in a brief colloquy?

This should have been an ongoing exercise over the last decade, in my opinion.